BioSpace News Archive

Drug Development

Boehringer Ingelheim Release: Ofev Demonstrates Consistent Long-Term Efficacy in IPF Regardless of Baseline Lung Function

Boehringer Ingelheim announced today the presentation of a new analysis on the use of Ofev (nintedanib) in treating people with idiopathic pulmonary fibrosis (IPF) at the 2017 CHEST Annual Meeting.

October 23, 2017

·

9 min read

Business

Invacare Corporation to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results

Invacare Corporation announces that it will release its financial results for the third quarter 2017, after the market closes on Tuesday, November 7, 2017.

October 23, 2017

·

2 min read

Business

QB3 Signs Partnership With Science Exchange, Giving Early Stage Life Science Companies Access to More than 2,500 Qualified Scientific Service Providers

Science Exchange, a platform for outsourced research and development (R&D) services, today announced a partnership with QB3, the University of California hub for innovation and entrepreneurship for life sciences.

October 23, 2017

·

3 min read

Drug Development

Inspyr Therapeutics Announces Research Collaboration With the National Institutes of Health

Dr. Elizabeth Kang initiates pre-clinical study for graft versus host disease.

October 23, 2017

·

3 min read

Drug Development

AIT Therapeutics Announces the Last Patient Has Completed Dosing in its Phase II NO-NTM Clinical Trial for Patients Suffering from Nontuberculous Mycobacteria (NTM) Abscessus

Data from the trial are expected to be communicated before the end of 2017.

October 23, 2017

·

4 min read

Business

Progenics Pharmaceuticals Sets Third Quarter 2017 Financial Results Call for November 2

A live webcast will be available in the Media Center of the Progenics website.

October 23, 2017

·

3 min read

FDA

United Therapeutics Announces FDA Approval of Third Generation Nebulizer for the Tyvaso Inhalation System

United Therapeutics today announced approval by the FDA of a new inhalation device, called the TD-300/A, for use with Tyvaso (treprostinil) Inhalation Solution (Tyvaso).

October 23, 2017

·

6 min read

BioMidwest

Hill-Rom Advances Patient Care, Safety and Satisfaction With Launch of New Centrella Smart+ Bed Solution

Hill-Rom today announced the launch of a new medical-surgical bed solution for hospitals that offers optimized patient safety, enhanced patient satisfaction and advanced caregiver-focused technology.

October 23, 2017

·

3 min read

Policy

AstraZeneca and Merck Rapidly Advance LYNPARZA (olaparib) in Japan With a Second Regulatory Submission

AstraZeneca and Merck announced that they have submitted a new drug application (NDA) to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for the use of LYNPARZA (olaparib) tablets in unresectable or recurrent BRCA-mutated breast cancer, with a decision expected in the second half of 2018.

October 23, 2017

·

12 min read

Peratech Raises $12.4M in Financing From Merck Ventures, Arie Capital and Existing Investors to Scale Up Technology Solutions

Peratech announced it has subscribed $12.4M to the round of funding, led by Merck Ventures the venture capital wing of Merck, along with Arie Capital and existing investors.

October 23, 2017

·

2 min read